Chanson International Holding announced on May 13, 2025, that its self-developed 'Songkang Meal' series of nasogastric nutrition formulas received official registration approval as a Food for Special Medical Purpose (FSMP) in China. This marks the company's pivotal expansion into the medical nutrition sector.
The 'Songkang Meal' series is designed to address specific medical dietary needs, particularly for patients with chronic conditions like diabetes and kidney disease, utilizing a low-glycemic index carbohydrate and plant-based protein blend. The product has already been adopted for use in several hospitals in Xinjiang.
Initial results from one hospital in Xinjiang showed 127 patients used the product, leading to increased nutritional compliance rates, and over 1,000 patients used 'Songkang Meal' in its first month on the market. This new product line represents a significant technological differentiator and a new, resilient revenue stream for Chanson.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.